Literature DB >> 35251623

Role of autophagy in drug resistance and regulation of osteosarcoma (Review).

Yanchuan Pu1, Jin Wang1, Shizhong Wang1.   

Abstract

Osteosarcoma (OS) is a malignant tumor originating from primitive mesenchymal tissue that occurs mostly in children and adolescents. It is the most common type of malignant tumor originating from bone. The combination of chemotherapy and surgery is an important treatment strategy for OS; however, multidrug resistance frequently leads to failure of chemotherapy for OS. Autophagy is considered an important mechanism through which bone tumor cells escape apoptosis; inhibition of autophagy may significantly increase the sensitivity of tumor cells to chemotherapeutic drugs. The present review discusses the relationship between chemotherapy resistance and autophagy-related genes, the regulation of autophagy in OS, as well as drugs that inhibit protective autophagy in tumors or cause autophagic death of OS cells or increase their sensitivity to chemotherapy drugs, thereby reducing chemotherapy resistance and increasing efficacy.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  autophagy; drug regulation; drug resistance; osteosarcoma

Year:  2022        PMID: 35251623      PMCID: PMC8848771          DOI: 10.3892/mco.2022.2505

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  65 in total

Review 1.  LINC01133: an emerging tumor-associated long non-coding RNA in tumor and osteosarcoma.

Authors:  Zheng Li; Derong Xu; Xin Chen; Shugang Li; Matthew T V Chan; William K K Wu
Journal:  Environ Sci Pollut Res Int       Date:  2020-06-19       Impact factor: 4.223

2.  Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation.

Authors:  Gautam Sethi; Kwang Seok Ahn; Manoj K Pandey; Bharat B Aggarwal
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

Review 3.  Photodynamic therapy of cancer: an update.

Authors:  Patrizia Agostinis; Kristian Berg; Keith A Cengel; Thomas H Foster; Albert W Girotti; Sandra O Gollnick; Stephen M Hahn; Michael R Hamblin; Asta Juzeniene; David Kessel; Mladen Korbelik; Johan Moan; Pawel Mroz; Dominika Nowis; Jacques Piette; Brian C Wilson; Jakub Golab
Journal:  CA Cancer J Clin       Date:  2011-05-26       Impact factor: 508.702

Review 4.  Survivin in solid tumors: rationale for development of inhibitors.

Authors:  David N Church; Denis C Talbot
Journal:  Curr Oncol Rep       Date:  2012-04       Impact factor: 5.075

5.  Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice.

Authors:  Huanjie Yang; Di Chen; Qiuzhi Cindy Cui; Xiao Yuan; Q Ping Dou
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

Review 6.  MicroRNAome genome: a treasure for cancer diagnosis and therapy.

Authors:  Ioana Berindan-Neagoe; Paloma del C Monroig; Barbara Pasculli; George A Calin
Journal:  CA Cancer J Clin       Date:  2014-08-07       Impact factor: 508.702

Review 7.  Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma.

Authors:  Zakir Khan; Abdul Arif Khan; Hariom Yadav; Godavarthi B K S Prasad; Prakash Singh Bisen
Journal:  Cell Mol Biol Lett       Date:  2017-04-05       Impact factor: 5.787

Review 8.  Triple negative breast cancer: special histological types and emerging therapeutic methods.

Authors:  Lu Cao; Yun Niu
Journal:  Cancer Biol Med       Date:  2020-05-15       Impact factor: 4.248

Review 9.  Insight Into the Role of Autophagy in Osteosarcoma and Its Therapeutic Implication.

Authors:  Jianfang Niu; Taiqiang Yan; Wei Guo; Wei Wang; Zhiqing Zhao
Journal:  Front Oncol       Date:  2019-11-15       Impact factor: 6.244

Review 10.  Mammalian Target of Rapamycin: Its Role in Early Neural Development and in Adult and Aged Brain Function.

Authors:  Carla Garza-Lombó; María E Gonsebatt
Journal:  Front Cell Neurosci       Date:  2016-06-16       Impact factor: 5.505

View more
  3 in total

1.  LncRNA SCAMP1 disrupts the balance between miR-26a-5p and ZEB2 to promote osteosarcoma cell viability and invasion.

Authors:  Rong Li; Zhen Chen; Yubo Zhou; Gulikezi Maimaitirexiati; Qi Yan; Yuting Li; Adilijiang Maimaitiyimin; Changhui Zhou; Jingqin Ren; Chengqing Liu; Abasi Mainike; Peng Zhou; Lu Ding
Journal:  Front Oncol       Date:  2022-08-03       Impact factor: 5.738

2.  Allicin Inhibits Osteosarcoma Growth by Promoting Oxidative Stress and Autophagy via the Inactivation of the lncRNA MALAT1-miR-376a-Wnt/β-Catenin Signaling Pathway.

Authors:  Wenpeng Xie; Wenjie Chang; Xiaole Wang; Fei Liu; Xu Wang; Daotong Yuan; Yongkui Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-06-24       Impact factor: 7.310

3.  ZCCHC12 promotes the progression of osteosarcoma via PI3K/AKT pathway.

Authors:  Yong Cui; Yong-Yong Dong
Journal:  Aging (Albany NY)       Date:  2022-09-19       Impact factor: 5.955

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.